Protocol in Reeducation Occupational Therapist in Coronary Patients
NCT ID: NCT04774276
Last Updated: 2023-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2020-11-02
2021-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Maintenance of Physical Condition and Physical Activity at One Year After Cardiac Rehabilitation Program
NCT04732923
Cardiac Rehabilitation Program in Patients with Cardiovascular Disease
NCT06211361
Effects of Cardiac Telerehabilitation During COVID-19 on Cardiorespiratory Capacities in Coronary Artery Disease Patients.
NCT05749744
Value of Cardiac Rehabilitation on the Treatment of Cardiovascular Disease
NCT05320848
Case-management Rehabilitation Intervention in Facilitating Return to Work After Myocardial Infarction
NCT04934735
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Goals : Evaluation of the quality of life of coronary heart patients who have benefited from cardiac rehabilitation optimized by secondary occupational therapy sessions:
Evaluation of aerobic and anaerobic performance of coronary heart patients who have benefited from cardiac rehabilitation optimized by occupational therapy sessions.
Evaluation of aerobic and anaerobic performance of coronary heart patients who have benefited from cardiac rehabilitation optimized by occupational therapy sessions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group with occupational therapist
Patient with Coronary Artery Disease (CAD) will be included. They will have the cardiac rehabilitation protocol (4 weeks) with occupational therapist as usual practice. The inclusion in this group will be prospective, from January 2021.
cardiac rehabilitation protocol with occupational therapist
This intervention (occupational therapist) have been added since 2021 for all patients who need a cardiac rehabilitation protocol.
Occupational therapy is scheduled with sessions 3 times a week for 1 month.
Group without occupational therapist
Patient with Coronary Artery Disease (CAD) will be included. They have done the cardiac rehabilitation protocol (4 weeks) without occupational therapist until december 2020. The inclusion in this group will be retrospective,
cardiac rehabilitation protocol without occupational therapist
cardiac rehabilitation protocol without occupational therapist will be performed (usual practice before January 2021).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cardiac rehabilitation protocol without occupational therapist
cardiac rehabilitation protocol without occupational therapist will be performed (usual practice before January 2021).
cardiac rehabilitation protocol with occupational therapist
This intervention (occupational therapist) have been added since 2021 for all patients who need a cardiac rehabilitation protocol.
Occupational therapy is scheduled with sessions 3 times a week for 1 month.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Included in the cardiac rehabilitation protocol in Saint Etienne university hospital
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
DAVID HUPIN, MD
Role: PRINCIPAL_INVESTIGATOR
CHU ST ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRBN022021/CHUSTE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.